Literature DB >> 1139070

Studies on the behavioural pharmacology of a cyclic analogue of dopamine following its injection into the brains of conscious rats.

A O Elkhawad, G N Woodruff.   

Abstract

1. The cyclic analogue of dopamine, 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) was injected into the lateral ventricle or bilaterally into the nucleus accumbens or caudate nucleus of conscious rats and its effect on locomotor activity was investigated. 2. When given intraventricularly, ADTN produced some stereotyped responses which were followed by a strong and long lasting stimulation of locomotor activity. When administered bilaterally into the nucleus accumbens a similar stimulation of locomotor activity was observed. ADTN had no effect on locomotor activity when injected bilaterally into the caudate nucleus. 3. The ADTN-induced locomotor stimulation following its intraventricular injection was completely abolished by a low dose of pimozide (0.01 mg/kg, i.p.) or haloperidol (0.5 mg/kg, i.p.). Pimozide (1 mg/kg, i.p.) given 30 min before ADTN injected bilaterally into the nucleus accumbens completely blocked locomotor stimulation. 4. Unilateral injections of ADTN (5 mug) into the nucleus accumbens caused locomotor stimulation but no turning. 5. Bilateral injections into the nucleus accumbens of 2-amino-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalene or 0.9 percent w/v NaCl solution had no effect on locomotor activity. 6. It is concluded that the central stimulant action of ADTN is due to an effect on the dopamine receptors in the nucleus accumbens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1139070      PMCID: PMC1666390          DOI: 10.1111/j.1476-5381.1975.tb07416.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  MECHANISM OF ACTION OF PSYCHOMOTOR STIMULANT DRUGS. SIGNIFICANCE OF DOPAMINE IN LOCOMOTOR STIMULANT ACTION.

Authors:  A T HURKMANS
Journal:  Int J Neuropharmacol       Date:  1964-05

2.  Proceedings: Increase in the cyclic AMP content of rat striatum produced by a cyclic analogue of dopamine.

Authors:  K A Munday; J A Poat; G N Woodruff
Journal:  J Physiol       Date:  1974-09       Impact factor: 5.182

3.  Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity.

Authors:  A S Horn; A C Cuello; R J Miller
Journal:  J Neurochem       Date:  1974-02       Impact factor: 5.372

4.  Ergometrine induced locomotor activity following intracerebral injection into the nucleus accumbens.

Authors:  A J Pijnenburg; G N Woodruff; J M van Rossum
Journal:  Brain Res       Date:  1973-09-14       Impact factor: 3.252

Review 5.  Mode of action of psychomotor stimulant drugs.

Authors:  J M Van Rossum
Journal:  Int Rev Neurobiol       Date:  1970       Impact factor: 3.230

6.  Aromatic amino acids and modification of parkinsonism.

Authors:  G C Cotzias; M H Van Woert; L M Schiffer
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

7.  Contrasting effects of hypothalamic and nucleus accumbens septi self-stimulation on brain stem single unit activity and cortical arousal.

Authors:  E T Rolls
Journal:  Brain Res       Date:  1971-08-20       Impact factor: 3.252

8.  Further evidence for the stimulation of rat brain dopamine receptors by a cyclic analogue of dopamine.

Authors:  G N Woodruff; A O Elkhawad; A R Crossman; R J Walker
Journal:  J Pharm Pharmacol       Date:  1974-09       Impact factor: 3.765

9.  A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain.

Authors:  E P Noble; R J Wurtman; J Axelrod
Journal:  Life Sci       Date:  1967-02-01       Impact factor: 5.037

10.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15
View more
  14 in total

1.  Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens.

Authors:  A R Cools
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Effect of the (+)-and (-)-enantiomers of sulpiride on ADTN-induced hyperactivity in the rat [proceedings].

Authors:  C D Andrews; G N Woodruff
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

3.  Effect of dihydroxy-2-aminotetralin derivatives on dopamine metabolism in the rat striatum.

Authors:  M G Feenstra; H Rollema; A S Horn; D Dijkstra; C J Grol; B H Westerink; A Westerbrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-01       Impact factor: 3.000

4.  Proceedings of the joint meeting of the Scandinavian and British Pharmacological Societies. Stockholm--Sweden. 5th and 6th July, 1982.

Authors: 
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

5.  Effects of intrapallidal drugs on hyperactivity induced by nucleus accumbens dopamine receptor stimulation.

Authors:  P Slater; D A Longman; S L Dickinson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

6.  Possible GABA-mediated control of dopamine-dependent behavioural effects from the nucleus accumbens of the rat.

Authors:  C J Pycock; R W Horton
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

7.  Effects of reserpine on dopamine metabolite in the nucleus accumbens and locomotor activity in freely moving rats.

Authors:  R Sugita; Y Sawa; S Nomura; S H Zorn; T Yamauchi
Journal:  Neurochem Res       Date:  1989-03       Impact factor: 3.996

8.  [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalen (ADTN). Regional distribution and in vivo binding after acute and chronic drug treatment.

Authors:  Y Clement-Cormier; C E Smith
Journal:  Neurochem Res       Date:  1980-06       Impact factor: 3.996

9.  The uptake and release of [3-H]-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthlane (ADTN) by striatal nerve terminals.

Authors:  A Davis; P J Roberts; G N Woodruff
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

10.  Uptake of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) into rat brain synaptosomes [proceedings].

Authors:  A Davis; P J Roberts; G N Woodruff
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.